Annual Report and Accounts Notice of Annual General Meeting: 27 June 2014

23rd May 2014 - 11:05 am

ImmuPharma PLC (AIM:IMM) (the “Company”)  the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2013 will be posted to shareholders today.

The Annual Report is available, in electronic form, for download on the Company’s website
The Company’s Annual General Meeting will be held on Friday 27 June 2014 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
Share this article